Trial Profile
Clinical Trials Insight: 700035680
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2009
Price :
$35
*
At a glance
- Drugs Adenosine triphosphate (Primary)
- Indications Paroxysmal supraventricular tachycardia
- Focus Registrational; Therapeutic Use
- Sponsors Cordex Pharma
- 02 Jun 2009 Status changed from planning to not yet recruiting, according to a Cordex Pharma media release.
- 18 Feb 2009 Amended phase III protocol submitted to FDA, according to a media release from Cordex Pharma.
- 20 Nov 2008 According to a Duska Therapeutics media release, this trial is expected to commence in quarter 1 of 2009.